A major concern people have when starting GLP-1 medications is that most of the weight lost will be muscle mass
See my options Research Snapshot Head-to-head comparison Regulatory status, labels, trial records, and sponsor updates can change quickly for obesity-drug pipeline pages
There are also microfocused ultrasound devices like Sofwave that zap targeted ultrasound energy deep into the skin, boosting collagen and delivering a tighter, lifted look
Share a complete list of your prescriptions, over-the-counter products, vitamins, and supplements so your clinician can check for interactions and adjust care as needed
53 LR] Roche announces positive Phase I results of its oral GLP-1 receptor agonist CT-996 for the treatment of people with obesity 2024-07-17 After four weeks of treatment, CT-996 demonstrated clinically meaningful weight loss of -7.3% (weight loss in placebo -1.2%